Free Trial
OTCMKTS:OREXQ

Orexigen Therapeutics (OREXQ) Stock Price, News & Analysis

$0.0053 +0.00 (+35.90%)
As of 05/31/2019

About Orexigen Therapeutics Stock (OTCMKTS:OREXQ)

Key Stats

Today's Range
$0.0027
$0.0053
50-Day Range
$0.0053
$0.0053
52-Week Range
$0.00
$0.16
Volume
60,300 shs
Average Volume
80,439 shs
Market Capitalization
$100.10 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products primarily in the United States, Europe, and South Korea. It offers Contrave for the treatment of obesity. The company also offers Contrave under the Mysimba brand name. Orexigen Therapeutics, Inc. was founded in 2002 and is headquartered in La Jolla, California. On March 12, 2018, Orexigen Therapeutics, Inc., filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Receive OREXQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Orexigen Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

OREXQ Stock News Headlines

Axsome Therapeutics Inc (AXSM)
Heron Therapeutics Inc HRTX
Think you missed gold’s boom? Think again
If you've been watching gold's historic run and wondering if it's too late… I've got good news. Because there's a $15 fund tied directly to gold's surge that's still paying massive income… Up to 64% annually — with payouts every 30 days.
See More Headlines

OREXQ Stock Analysis - Frequently Asked Questions

Orexigen Therapeutics' stock was trading at $0.0053 on January 1st, 2025. Since then, OREXQ shares have increased by 0.0% and is now trading at $0.0053.
View the best growth stocks for 2025 here
.

Shares of OREXQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:OREXQ
Fax
N/A
Employees
132
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$33.71 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$100.10 thousand
Optionable
Not Optionable
Beta
4.98
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (OTCMKTS:OREXQ) was last updated on 6/28/2025 by MarketBeat.com Staff
From Our Partners